Challenges in The Management ofKallmann Syndrome : A Case Report

Authors

  • Saiful Anam Endocrinology Metabolism and Diabetes Resident, Departement of Internal Medicine Dr. Sardjito General Hospital/Faculty of Medicine, Public Health and Nursing, Gadjah Mada University, Yogyakarta, Indonesia Author
  • R. Bowo Pramono Endocrinology Metabolism and Diabetes Division, Departement of Internal Medicine Dr. Sardjito General Hospital/Faculty of Medicine, Public Health and Nursing, Gadjah Mada University, Yogyakarta, Indonesia Author

DOI:

https://doi.org/10.66266/inajemd.v2i2.63

Keywords:

Kallmann syndrome, small penis, gynecomastia, testosteron undecanoate, surgery

Abstract

Background: Kallman syndrome is combined disorder of hypogonadotropic hypogonadism and anosmia. Incidence of congenital hypogonadotropic hypogonadism is 1-10:100,000 live
births, and approximately 2/3 and 1/3 of cases are caused by Kallmann syndrome and idiopathic hypogonadotropic hypogonadism, respectively.
Case illustration: We report a man, 35 years old, with complaints of small penis, small voice, impaired smell, gynecomastia, narrowing of visual field, mustache not growing, little pubic and armpit hair. Patient underwent surgery on both breasts with histopathological results of gynecomastia, no malignancy. Testicular ultrasound results showed bilateral testicular atrophy. Laboratory results showed karyotype 46XY, Follicle-stimulating hormone 1.79 mIU/mL, Luteinizing hormone 1.49 mIU/mL, testosterone <0.03 ng/mL, estradiol 5.0 pg/mL, prolactin 6.75 ng/mL and prostate-specific antigen 0.473 ng/mL. Head CT scan imaging showed bilateral otitis media, mastoiditis and sinusitis. Patient was diagnosed Kallmann syndrome, anxiety and depression symptoms (ADS) chronic tubotympanic suppurative otitis media, sinusitis, oculus dexter and sinister hemianopsia. Patient was treated with testosterone undecanoate injection 1000 mg IM every 3 months, levofloxacin 500 mg PO once daily, avamys nasal spray twice daily.
Discussion: Symptoms of Kallman syndrome can include absent or incomplete pubertal development, anosmia or hyposmia, and low sex steroid levels. KAL1 gene mutations cause Gonadotropin-releasing hormone (GnRH) deficiency, associated with Kallmann syndrome. Testosteron replacement is indicated for men who already have children or have no desire for children. Surgery should be considered as the last option in patients with considerable discomfort, psychological stress, cosmetic problems, long‑standing gynecomastia (>12 months) and suspected malignancy.
Conclusion: The aim of testosterone therapy is to reverse the symptoms of hypogonadism, and surgery is last option in patients with considerable discomfort.

Downloads

Download data is not yet available.

References

1. Dode, C., and Hardelin, J. P, 2009, Kallman

syndrome, European Journal of Human Genetics,

17: 139–146, doi:10.1038/ejhg.2008.206.

2. Fraietta, R., Zylberstejn, D.S., EstevesI, S.C.,

2013, Hypogonadotropic hypogonadism

revisited, Clinics, 68 (51): 81-88, doi. 10.6061/

clinics/2013(Sup01)09.

3. Young, J., Xu, C., Papadakis, G. E., Acierno, J. S.,

Maione, L., Hietamaki, J., Raivio, T., Pitteloud,

N., 2019, Clinical management of congenital

hypogonadotropic hypogonadism, Endocrine

Reviews, 40: 669-710, doi. 10.1210/er.2018-

00116.

4. Laitinem, E. M., Vaaralahti, K.,Incidence, Tommiska,

J., Eklund, E., Tervaniemi, M., Valanne, L., Raivio,

T., 2011, Phenotypic features and molecular

genetics of Kallmann syndrome in Finland,

Orphanet Journal of Rare Diseases, 6: 41.

5. Cuhaci, N., Polat, S. B., Evranos, B., Ersoy, R., Cakir,

B., 2014, Gynecomastia: Clinical evaluation and

management, Indian Journal of Endocrinology and

Metabolism, vol 18: 150-158, doi.10.4103/2230-

8210.129104.

6. Kanakis, G. A., Nordkap, L., Bang, A. K., Calogero,

A. E., Artfai, G. B., Corona, G., Forti, G., Toppari,

J., Goulis, D. G., Jorgensen, N., 2019, EAA clinical

practice guidelines- gynecomastia evaluation

and management, American Society of Andrology

and European Academy of Andrology, 7: 778-793,

doi.10.1111/andr.12636.

7. Sagi, S. V., Joshi, H., Whiles, E., Hikmat, M., Puthi,

V. R., MacDougall, J., Spiden, S.. L., Fuller, G., Park,

S. M., Oyibo, S. O., 2020, Normosmic idiopathic

hypogonadotropic hypogonadism due to a novel

GNRH1 variant in two siblings, Endocrinology

Diabetes and Metabolism, doi.10.1530/EDM-

19-0145.

8. Liu, Y., and Zhi, X., 2021, Advances in Genetic

Diagnosis of Kallmann Syndrome and Genetic

Interruption, Reproductive Sciences, 6 :1-13, doi.

org/10.1007/s43032-021- 00638-8.

Downloads

Published

01-12-2025

How to Cite

1.
Saiful Anam, R. Bowo Pramono. Challenges in The Management ofKallmann Syndrome : A Case Report. InaJEMD [Internet]. 2025 Dec. 1 [cited 2026 Apr. 12];2(2):47-55. Available from: https://inajemd.pbperkeni.or.id/index.php/journal/article/view/vol2no2-7

Similar Articles

1-10 of 14

You may also start an advanced similarity search for this article.